Pub Date : 2021-12-09DOI: 10.1016/j.jimed.2021.12.002
Yong Li, Jianxi Guo, Yanfang Zhang, Jian Kong
{"title":"Complications from port-a-cath system implantation in adults with malignant tumors: A 10-year single-center retrospective study","authors":"Yong Li, Jianxi Guo, Yanfang Zhang, Jian Kong","doi":"10.1016/j.jimed.2021.12.002","DOIUrl":"https://doi.org/10.1016/j.jimed.2021.12.002","url":null,"abstract":"","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"189 1","pages":"15 - 22"},"PeriodicalIF":0.0,"publicationDate":"2021-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77271498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-12-01DOI: 10.1016/j.jimed.2021.12.004
M. Razi, S. Safiullah, J. Gu, Xu He, M. Razi, J. Kong
{"title":"Comparison of tumor response following conventional versus drug-eluting bead transarterial chemoembolization in early- and very early-stage hepatocellular carcinoma","authors":"M. Razi, S. Safiullah, J. Gu, Xu He, M. Razi, J. Kong","doi":"10.1016/j.jimed.2021.12.004","DOIUrl":"https://doi.org/10.1016/j.jimed.2021.12.004","url":null,"abstract":"","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"50 1","pages":"10 - 14"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80754005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt created through left or right branches of the portal vein: A meta-analysis","authors":"Shaobo Zhai, Qi Cui, Fang Dong, Shiqi Wen, Moubo Si, Quan-jing Chen","doi":"10.1016/j.jimed.2021.08.002","DOIUrl":"https://doi.org/10.1016/j.jimed.2021.08.002","url":null,"abstract":"","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"10 1","pages":"190 - 196"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75468084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-11-01DOI: 10.1016/j.jimed.2021.10.001
Chen Wan, B. Zhou
{"title":"Research progress on circulating tumor cells of hepatocellular carcinoma","authors":"Chen Wan, B. Zhou","doi":"10.1016/j.jimed.2021.10.001","DOIUrl":"https://doi.org/10.1016/j.jimed.2021.10.001","url":null,"abstract":"","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"109 1","pages":"181 - 183"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91334902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-11-01DOI: 10.1016/j.jimed.2021.10.002
Yu He, Shilong Han, Chun-ling Wu, Fei Ge, Jianbo Wang
{"title":"Comparison of the postoperative pain change and spinal stenosis rate between percutaneous vertebroplasty combined with radiofrequency ablation and with 125I particle implantation in the treatment of metastatic spinal cord compression: A retrospective study","authors":"Yu He, Shilong Han, Chun-ling Wu, Fei Ge, Jianbo Wang","doi":"10.1016/j.jimed.2021.10.002","DOIUrl":"https://doi.org/10.1016/j.jimed.2021.10.002","url":null,"abstract":"","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"28 1","pages":"197 - 202"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74002012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-11-01DOI: 10.1016/j.jimed.2021.10.003
Xiaoyun Zhao, Xingwei Sun, J. Jing, Huimin Zhou, Yong Jin
{"title":"Safety study of Folfox-HAIC in relieving bed restriction","authors":"Xiaoyun Zhao, Xingwei Sun, J. Jing, Huimin Zhou, Yong Jin","doi":"10.1016/j.jimed.2021.10.003","DOIUrl":"https://doi.org/10.1016/j.jimed.2021.10.003","url":null,"abstract":"","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"65 1","pages":"203 - 207"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80354028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-08-01DOI: 10.1016/j.jimed.2021.05.002
Jian Xue, Hongbo Ni, Fan Wang, Ke Xu, Meng Niu
Locoregional therapies (LRTs) of hepatocellular carcinoma (HCC) represented by ablation and TACE has become the main means for the clinical treatment of unresectable HCC. Among these, TACE is used throughout the stage Ib to IIIb of HCC treatment. In recent years, immunotherapy led by immune checkpoint inhibitors has become a hot direction in clinical research. At the same time, targeted drugs such as Sorafenib and Apatinib have played an important role in the treatment and complementary therapy of advanced HCC, and their clinical application has been quite mature. HCC is the sixth most common malignant tumor in the world. When it comes to its treatment, different therapies have different indications, and their individual efficacies are not satisfactory, which makes the exploration of the use of combination therapy in HCC treatment become a new trend. In this paper, the status of the three therapies and the progress of their combined application are briefly reviewed.
{"title":"Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy","authors":"Jian Xue, Hongbo Ni, Fan Wang, Ke Xu, Meng Niu","doi":"10.1016/j.jimed.2021.05.002","DOIUrl":"10.1016/j.jimed.2021.05.002","url":null,"abstract":"<div><p>Locoregional therapies (LRTs) of hepatocellular carcinoma (HCC) represented by ablation and TACE has become the main means for the clinical treatment of unresectable HCC. Among these, TACE is used throughout the stage Ib to IIIb of HCC treatment. In recent years, immunotherapy led by immune checkpoint inhibitors has become a hot direction in clinical research. At the same time, targeted drugs such as Sorafenib and Apatinib have played an important role in the treatment and complementary therapy of advanced HCC, and their clinical application has been quite mature. HCC is the sixth most common malignant tumor in the world. When it comes to its treatment, different therapies have different indications, and their individual efficacies are not satisfactory, which makes the exploration of the use of combination therapy in HCC treatment become a new trend. In this paper, the status of the three therapies and the progress of their combined application are briefly reviewed.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"4 3","pages":"Pages 105-113"},"PeriodicalIF":0.0,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jimed.2021.05.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39645852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}